Literature DB >> 31355713

Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.

John Cologne1, Jaeyoung Kim2, Hiromi Sugiyama3, Benjamin French1, Harry M Cullings1, Dale L Preston4, Kiyohiko Mabuchi5, Kotaro Ozasa3.   

Abstract

A recent analysis of solid cancer incidence in the Life Span Study of atomic bomb survivors (Hiroshima and Nagasaki, Japan) found evidence of a nonlinear, upwardly curving radiation dose response among males but not among females. Further analysis of this new and unexpected finding was necessary. We used two approaches to investigate this finding. In one approach, we excluded individual cancer sites or groups of sites from all solid cancers. In the other approach, we used joint analysis to allow for heterogeneity in background-rate parameters across groups of cancers with dissimilar trends in background rates. Exclusion of a few sites led to the disappearance of curvature among males in the remaining collection of solid cancers; some of these influential sites have unique features in their background age-specific incidence that are not captured by a background-rate model fit to all solid cancers combined. Exclusion of a few sites also led to an appearance of curvature among females. Misspecification of background rates can cause bias in inference about the shape of the dose response, so heterogeneity of background rates might explain at least part of the all solid cancer dose-response difference in curvature between males and females. We conclude that analysis based on all solid cancers as a single outcome is not the optimal method to assess radiation risk for solid cancer in the Life Span Study; joint analysis with suitable choices of cancer groups might be preferable by allowing for background-rate heterogeneity across sites while providing greater power to assess radiation risk than analyses of individual sites.

Entities:  

Mesh:

Year:  2019        PMID: 31355713      PMCID: PMC6827345          DOI: 10.1667/RR15127.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  28 in total

1.  Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors.

Authors:  J B Cologne; D L Preston
Journal:  Health Phys       Date:  2001-05       Impact factor: 1.316

2.  Hierarchical regression for analyses of multiple outcomes.

Authors:  David B Richardson; Ghassan B Hamra; Richard F MacLehose; Stephen R Cole; Haitao Chu
Journal:  Am J Epidemiol       Date:  2015-07-30       Impact factor: 4.897

3.  Dependent censoring in piecewise exponential survival models.

Authors:  N D Staplin; A C Kimber; D Collett; P J Roderick
Journal:  Stat Methods Med Res       Date:  2014-07-17       Impact factor: 3.021

4.  Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.

Authors:  Elizabeth K Cahoon; Dale L Preston; Donald A Pierce; Eric Grant; Alina V Brenner; Kiyohiko Mabuchi; Mai Utada; Kotaro Ozasa
Journal:  Radiat Res       Date:  2017-03-21       Impact factor: 2.841

5.  Ionizing radiation and kidney cancer among Japanese atomic bomb survivors.

Authors:  David B Richardson; Ghassan Hamra
Journal:  Radiat Res       Date:  2010-06       Impact factor: 2.841

6.  Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.

Authors:  Kotaro Ozasa; Yukiko Shimizu; Akihiko Suyama; Fumiyoshi Kasagi; Midori Soda; Eric J Grant; Ritsu Sakata; Hiromi Sugiyama; Kazunori Kodama
Journal:  Radiat Res       Date:  2011-12-15       Impact factor: 2.841

7.  Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.

Authors:  Kyoji Furukawa; Dale Preston; Sachiyo Funamoto; Shuji Yonehara; Masahiro Ito; Shoji Tokuoka; Hiromi Sugiyama; Midori Soda; Kotaro Ozasa; Kiyohiko Mabuchi
Journal:  Int J Cancer       Date:  2012-08-16       Impact factor: 7.396

8.  Solid cancer incidence in atomic bomb survivors: 1958-1998.

Authors:  D L Preston; E Ron; S Tokuoka; S Funamoto; N Nishi; M Soda; K Mabuchi; K Kodama
Journal:  Radiat Res       Date:  2007-07       Impact factor: 2.841

Review 9.  Thyroid Growth and Cancer.

Authors:  Dillwyn Williams
Journal:  Eur Thyroid J       Date:  2015-08-26

10.  Radiation Risks of Uterine Cancer in Atomic Bomb Survivors: 1958-2009.

Authors:  Mai Utada; Alina V Brenner; Dale L Preston; John B Cologne; Ritsu Sakata; Hiromi Sugiyama; Atsuko Sadakane; Eric J Grant; Elizabeth K Cahoon; Kotaro Ozasa; Kiyohiko Mabuchi
Journal:  JNCI Cancer Spectr       Date:  2019-02-08
View more
  3 in total

1.  High CT doses return to the agenda.

Authors:  W Rühm; R M Harrison
Journal:  Radiat Environ Biophys       Date:  2019-12-16       Impact factor: 1.925

2.  Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.

Authors:  Mark P Little; David Pawel; Munechika Misumi; Nobuyuki Hamada; Harry M Cullings; Richard Wakeford; Kotaro Ozasa
Journal:  Radiat Res       Date:  2020-09-16       Impact factor: 2.841

3.  Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases.

Authors:  Anna Ostropolets; Xintong Li; Rupa Makadia; Gowtham Rao; Peter R Rijnbeek; Talita Duarte-Salles; Anthony G Sena; Azza Shaoibi; Marc A Suchard; Patrick B Ryan; Daniel Prieto-Alhambra; George Hripcsak
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.